Methotrexate in nonrenal lupus and undifferentiated connective tissue disease - A review of 36 patients

Journal of Rheumatology

Volumn 23, Issue 6, 1996, Pages 1005-1010

  Wise, Christopher M ^a,b   Vuyyuru, Sujatha ^a   Roberts, W Neal ^a,b  

^a VIRGINIA COMMONWEALTH UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Department of Internal Medicine ^*  (United States)

Author keywords

METHOTREXATE; SYSTEMIC LUPUS ERYTHEMATOSUS

Indexed keywords

AZATHIOPRINE; HYDROXYCHLOROQUINE; METHOTREXATE; PREDNISONE;

ADOLESCENT; ADULT; ARTICLE; CLINICAL TRIAL; CONNECTIVE TISSUE DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; MALE; MOUTH ULCER; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RASH; STOMATITIS; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT OUTCOME;

ADOLESCENT; ADRENAL CORTEX HORMONES; ADULT; CONNECTIVE TISSUE DISEASES; FEMALE; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; METHOTREXATE; MIDDLE AGED; RETROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 0030011039     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Weinblatt ME, Weissman, BN, Holdsworth DE, et al: Long-term prospective study of methotrexate in the treatment of rheumatoid arthritis: 84-month update. Arthritis Rheum 1992;35:129-37.
2. Kremer JM, Phelps CT: Long-term prospective study of the use of methotrexate in the treatment of rheumatoid arthritis: Update after a mean of 90 months. Arthritis Rheum 1992;35:138-45.
3. Weinblatt ME: Methotrexate. In: Kelley WN, Harris ED, Ruddy S, Sledge CB, eds. Textbook of Rheumatology 4th ed. Philadelphia: WB Saunders, 1993: 767-78.
4. Quismorio FP: Systemic corticosteroid therapy in systemic lupus erythematosus. In: Wallace DJ, Hahn BH, eds. Dubois' Lupus Erythematosus. 4th ed. Philadelphia: Lea and Febiger, 1993: 574-87.
5. Wallace DJ: Antimalarial drugs and lupus. Rheum Dis Clin North Am 1994;20:243-64.
6. Fox DA, McCune WJ: Immunosuppressive drug therapy of systemic lupus erythematosus. Rheum Dis Clin North Am 1994;20:265-300.
7. Miescher PA, Riethmuller D: Diagnosis and treatment of systemic lupus erythematosus. Semin Hematol 1965;2:1-28.
8. Swanson MA, Schwartz RS: Immunosuppressive therapy: The relation between clinical response and immunologic competence. N Engl J Med 1967;277:163-97.
9. Dubois EL: Management of discoid and systemic lupus erythematosus: A review of the current status of discoid and systemic lupus erythematosus and their variants. In: Dubois EL, ed. Systemic Lupus Erythematosus. Los Angeles: University of Southern California Press, 1974:537-612.
10. Davidson JR, Graziano FM, Rothenberg RJ: Methotrexate therapy for severe systemic lupus erythematosus (letter). Arthritis Rheum 1987;30:1195-6.
11. Rothenberg RJ, Graziano RM, Grandone JT, Goldberg JW, Bjarnason DF, Finesilver AG: The use of methotrexate in steroid-resistant lupus erythematosus. Arthritis Rheum 1988;31:612-5.
12. Wilke WS, Krall PL, Scheetz RJ, et al: Methotrexate for systemic lupus erythematosus: A retrospective analysis of 17 unselected cases. Clin Exp Rheumatol 1991;9:581-7.
13. Abud-Mendoza C, Sturbaum AK, Vazquez-Compean R, Gonzalez-Amaro R: Methotrexate therapy in childhood systemic lupus erythematosus. J Rheumatol 1993;20:731-3.
14. Walz LeBlanc BAE, Dagenais P, Urowitz MB, Gladman DD: Methotrexate in systemic lupus erythematosus. J Rheumatol 1994; 21:836-8.
15. Wilson K, Abeles M: A 2 year, open ended trial of methotrexate in systemic lupus erythematosus. J Rheumatol 1994;21:1674-7.
16. Tan EM, Cohen AS, Fries JF, et al: The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1982;25:1271-7.
17. Liang MH, Socher SA, Larson MG, Schur PH: Reliability and validity of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 1989;32:1107-18.
18. Kalunian KC: Definition, classification, and activity indices. In: Wallace DJ, Hahn BH, eds. Dubois' Lupus Erythematosus. 4th ed. Philadelphia. Lea and Febiger, 1993: 58-63.
19. Morand EF, McCloud PI, Littlejohn GO: Life table analysis of 879 treatment episodes with slow acting antirheumatic drugs in community rheumatology practice. J Rheumatol 1992;19:704-8.
20. Pincus T, Marcum SB, Callahan LF: Longterm drug therapy for rheumatoid arthritis in seven rheumatology private practices. II. Second line drugs and prednisone. J Rheumatol 1992;19:1885-94.